Orthofix Medical Inc. (OFIX) earnings
OFIX earnings moved a median of +0.54% by the close. Quarterly and annual OFIX reports and results, each read against the price at its own news timestamp. Back to the OFIX overview →
30 measured OFIX earnings events.
Where these OFIX earnings landedvs 30 measured OFIX earnings reactions
| Middle 50% of OFIX earnings reactions | -2.33% to +4.08% |
|---|---|
| Median reaction (to close) | +0.54% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 OFIX earnings events with a measured close landed between -2.33% and +4.08%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Orthofix Medical Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.65% | -15.01% | |
| Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress | Press release | -8.65% | -15.01% | |
| Orthofix to Report Second Quarter 2026 Financial Results | Press release | +0.18% | +3.29% | |
| Form 10-Q Orthofix Medical Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.88% | +3.75% | |
| Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance | Press release | -1.88% | +3.75% | |
| Orthofix to Report First Quarter 2026 Financial Results | Press release | -0.08% | -4.50% | |
| Form 10-K Orthofix Medical Inc. For: Dec 31 | SEC filing · Form 10-K | -1.11% | -5.97% | |
| Form 10-Q Orthofix Medical Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.94% | -9.71% | |
| Orthofix Reports Third Quarter 2025 Financial Results | Press release | -2.94% | -9.71% | |
| Orthofix to Report Third Quarter 2025 Financial Results | Press release | +1.05% | +3.14% | |
| Form 10-Q Orthofix Medical Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.54% | +2.41% | |
| Orthofix Reports Second Quarter 2025 Financial Results | Press release | +0.54% | +2.41% | |
| Orthofix to Report Second Quarter 2025 Financial Results | Press release | +0.18% | -2.80% | |
| Form 10-Q Orthofix Medical Inc. For: Mar 31 | SEC filing · Form 10-Q | +10.25% | +8.45% | |
| Orthofix Reports First Quarter 2025 Financial Results | Press release | +10.25% | +8.45% | |
| Orthofix to Report First Quarter 2025 Financial Results | Press release | -0.67% | -0.15% | |
| Form 10-K Orthofix Medical Inc. For: Dec 31 | SEC filing · Form 10-K | +8.30% | -7.40% | |
| Form 10-Q Orthofix Medical Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.15% | -0.44% | |
| Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets | Press release | +1.15% | -0.44% | |
| Orthofix to Report Third Quarter 2024 Financial Results | Press release | -1.06% | -0.20% | |
| Form 10-Q Orthofix Medical Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.72% | +6.21% | |
| Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance | Press release | -4.72% | +6.21% | |
| Orthofix to Report Second Quarter 2024 Financial Results | Press release | +0.28% | +4.18% | |
| Form 10-Q Orthofix Medical Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.14% | +10.33% | |
| Orthofix Reports First Quarter 2024 Results | Press release | +3.14% | +10.33% | |
| Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 | Press release | +2.60% | +1.23% | |
| Form 10-K Orthofix Medical Inc. For: Dec 31 | SEC filing · Form 10-K | +2.96% | +8.69% | |
| Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024 | Press release | -0.66% | -0.15% | |
| Form 10-Q Orthofix Medical Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.25% | -0.93% | |
| Orthofix Reports Third Quarter 2023 Results | Press release | +0.25% | -0.93% |
Keep exploring
More OFIX: analyst actions → · SEC filings → · OFIX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | 1,226 | +0.05% | 52% |
| Sarepta Therapeutics, Inc. (SRPT) | 1,224 | -0.30% | 44% |
| IMMUNOMEDICS (IMMU) | 1,213 | -0.08% | 45% |
| Biogen Inc. (BIIB) | 1,208 | -0.01% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.